Dr. Randy B. Feldman, MD

Dr. Feldman practices at Cedars-Sinai Marina Hospital in Marina Del Rey, California, part of Cedars-Sinai Health System.

Dr. Feldman's NPI, 1538192588, was assigned on July 9, 2006. Dr. Feldman graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Feldman holds California license A67543.

Dr. Feldman's primary practice is Cedars-Sinai Marina Hospital, at 4650 Lincoln Blvd, Marina Del Rey, CA 90292 in Los Angeles County. The practice phone is (310) 823-8911.

Dr. Feldman's primary practice is Cedars-Sinai Marina Hospital in Marina Del Rey, California, part of Cedars-Sinai Health System. Dr. Feldman is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Comprehensive Care ID Medical Group. Dmand AI also links Dr. Feldman to 2 more group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Feldman is board certified in infectious disease by the American Board of Internal Medicine. Dr. Feldman is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, bronchitis, facial skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Feldman treats.

CMS data shows 3,371 Medicare services from Dr. Feldman across 7 procedure codes in 2024, for 604 Medicare patients. Medicare paid $272,664 for them.

CMS counts 604 Medicare patients who saw Dr. Feldman in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 71, with 41% women.

In 2024, Dr. Feldman wrote 726 Medicare Part D claims for 126 patients. 77% of them were for generic drugs. CMS names the drug for 566 of them, across 25 drugs with 11 or more claims each, at $529,673 in total drug cost. In 2023, CMS named 476 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Feldman for performance year 2024, reported as part of a group. Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feldman as offering telehealth.

CMS Open Payments shows 19 general payments to Dr. Feldman from 5 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 53% of the total. Gilead Sciences, Inc. paid the most, $2,822.

Dmand AI lists 1 award for Dr. Feldman, most recently CMS Stage 1 EHR in 2013.

Dr. Feldman graduated from David Geffen School of Medicine at UCLA in 1997. Dr. Feldman is a member of ACP.

Dr. Feldman is in network with 10 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.